Arş. Gör. HEYBET KEREM POLAT | AVESİS

Akademik Veri Yönetim Sistemi

Yayınlar & Eserler

Makaleler 9

1. Optimizing riboflavin delivery with co-crystal and in situ hydrogel formulations for management of keratoconus: A comprehensive investigation with in vitro, ex vivo and in vivo studies

AYTEKİN E., Kaya M. Z., POLAT H. K., ÇAKMAK H. B., ÇELEBİER M., PALASKA E., et al.

INTERNATIONAL JOURNAL OF PHARMACEUTICS , cilt.674, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

Sürdürülebilir Kalkınma

2. Harnessing silk fibroin microparticles for metformin delivery: A novel approach to treating corneal neovascularization

Polat H. K., AYTEKİN E., KARAKUYU N. F., Çaylı Y., ÇALAMAK S., Demirci N., et al.

JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY , cilt.96, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

Sürdürülebilir Kalkınma

3. Formulation of hesperidin-loaded in situ gel for ocular drug delivery: a comprehensive study

GÖZCÜ S., Polat H. K., Gültekin Y., ÜNAL S., KARAKUYU N. F., Şafak E. K., et al.

Journal of the Science of Food and Agriculture , 2024 (SCI-Expanded, Scopus)

4. Development and characterization of in situ gelling system containing atorvastatin-loaded polycaprolactone nanoparticles for periodontal diseases

ÜNAL S., Doğan O., Polat H. K., AKTAŞ Y.

Journal of Research in Pharmacy , cilt.27, sa.5, ss.1951-1973, 2023 (ESCI, Scopus, TRDizin)

Creative Commons License

5. Formulation development of Lornoxicam loaded heat triggered ocular in-situ gel using factorial design

Polat H. K., ÜNAL S., AYTEKİN E., KARAKUYU N. F., PEZİK E., HAYDAR M. K., et al.

Drug Development and Industrial Pharmacy , cilt.49, sa.9, ss.601-615, 2023 (SCI-Expanded, Scopus)

6. Design of Besifloxacin HCl-Loaded Nanostructured Lipid Carriers: In Vitro and Ex Vivo Evaluation

POLAT H. K., Kurt N., AYTEKİN E., AKDAĞ ÇAYLI Y., Pehlivan S., ÇALIŞ S.

JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS , cilt.38, sa.6, ss.412-423, 2022 (SCI-Expanded, Scopus)

7. Novel Drug Delivery Systems to Improve the Treatment of Keratitis

POLAT H. K., Kurt N., AYTEKİN E., Pehlivan S. B., ÇALIŞ S.

JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS , cilt.38, sa.6, ss.376-395, 2022 (SCI-Expanded, Scopus)

8. Design of ocular drug delivery platforms and in vitro - in vivo evaluation of riboflavin to the cornea by non-interventional (epi-on) technique for keratoconus treatment

AYTEKİN E., ÖZTÜRK N., Vurla İ., POLAT H. K., Cakmak H. B., ÇALIŞ S., et al.

Journal of Controlled Release , cilt.324, ss.238-249, 2020 (SCI-Expanded, Scopus)

9. Development of besifloxacin HCl loaded nanofibrous ocular inserts for the treatment of bacterial keratitis: In vitro, ex vivo and in vivo evaluation

POLAT H. K., Pehlivan S. B., Ozkul C., ÇALAMAK S., Ozturk N., AYTEKİN E., et al.

INTERNATIONAL JOURNAL OF PHARMACEUTICS , cilt.585, 2020 (SCI-Expanded, Scopus)

Metrikler

Yayın

10

Yayın (WoS)

9

Yayın (Scopus)

9

Atıf (WoS)

40

H-İndeks (WoS)

3

Atıf (Scopus)

44

H-İndeks (Scopus)

3

Açık Erişim

1

BM Sürdürülebilir Kalkınma Amaçları